Clinical Center Nis

Niš, Nišavski Okrug 18000

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Crohn's Disease, Severe Acute Respiratory Syndrome Coronavirus 2

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 — Completed